Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2017-12-04 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
第七届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the seventh board of directors' sixth meeting of the company 普洛药业股份有限公司. It includes details about the appointment of a new deputy general manager, approval of capital increase in a subsidiary, amendments to the company bylaws, shareholder return plans, and the notice of an upcoming extraordinary general meeting. The document contains voting results and compliance statements but does not include financial statements or detailed financial analysis. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1175 characters), and it is not a report or presentation but an official announcement of board decisions.
2017-12-04 Chinese
独立董事关于聘任公司副总经理的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the company's independent directors regarding the appointment of a deputy general manager. It references compliance with regulatory guidelines and company bylaws, and provides an approval statement. The document is short (516 characters) and does not contain financial data or detailed management changes but is related to management appointment approval. This fits best under Board/Management Information (MANG) as it concerns management appointment and independent directors' opinion on it.
2017-12-04 Chinese
公司章程修订案
Governance Information Classification · 95% confidence The document is titled "公司章程修订案" which translates to "Amendment to the Articles of Association" of 普洛药业股份有限公司. It details specific changes to the company's articles, including changes to registered capital, board structure, and decision-making processes. The document references board meetings and shareholder meetings approving these amendments. There is no financial data, earnings information, or audit content. It is not a report or announcement of financial results but a governance-related document concerning internal company rules and structure. Therefore, it fits the category of Governance Information (CGR). The document length is 2106 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, the classification is CGR with high confidence.
2017-12-04 Chinese
独立董事关于对公司未来三年股东回报规划之独立意见
Notice of Dividend Amount Classification · 85% confidence The document is an independent opinion from the independent directors regarding the company's future three-year shareholder return plan (2017-2019). It discusses the dividend policy, profit distribution principles, and compliance with regulatory requirements. It is not a full financial report, earnings release, or regulatory filing but rather a governance-related statement about shareholder returns and dividend planning. The document is relatively short (814 characters) and focuses on the independent directors' opinion on the dividend policy and shareholder return plan, which aligns with Remuneration Information or Dividend Notice categories. However, since it is about the shareholder return plan and dividend policy rather than announcing a specific dividend amount or payment date, it fits best under Notice of Dividend Amount (DIV) as it relates to dividend planning and shareholder returns. Confidence is high due to clear references to dividend policy and shareholder return planning.
2017-12-04 Chinese
未来三年（2017年—2019年）股东回报规划
Governance Information Classification · 95% confidence The document is titled '未来三年（2017 年—2019 年）股东回报规划' which translates to 'Future Three-Year (2017-2019) Shareholder Return Plan'. It outlines the company's dividend policy and shareholder return strategy over a multi-year period. The content focuses on the company's planned approach to profit distribution, including cash dividends and stock dividends, principles for dividend payout, decision-making and adjustment mechanisms, and communication with shareholders. There is no financial statement data, no audit information, no earnings results, no management discussion of financial results, no legal proceedings, no capital raising, no voting results, and no meeting materials. The document is a formal announcement of the company's dividend policy plan for the next three years, which is a strategic governance-related disclosure. It is not a report of actual dividends declared or paid, nor is it a proxy or voting result. It is also not a regulatory filing or certification. Given the focus on governance of shareholder returns and dividend policy, the best fitting category is Governance Information (CGR). The document length is 2141 characters, which is relatively short and consistent with a policy announcement rather than a full report.
2017-12-04 Chinese
关于收到公司监事辞职和选举监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of two company supervisors and the election of new supervisors. It includes details about the resignations, the reasons, and the process for electing new supervisors. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this personnel change. This fits the category of Board/Management Information, which covers announcements of changes in the company's board or senior management.
2017-12-04 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.